Optimal post-remission therapy for flow-cytometry minimal residual disease positive patients with acute myeloid leukemia

被引：0
|
作者：
Venditti, A. [1 ]
Buccisano, F. [1 ]
Maurillo, L. [1 ]
Del Principe, M. I. [1 ]
Del Poeta, G. [1 ]
Ottaviani, L. [1 ]
Sarlo, C. [1 ]
Ammatuna, E. [1 ]
Fraboni, D. [1 ]
Imo-Consalvo, M. [1 ]
Amadori, S. [1 ]
机构：
[1] Univ Roma Tor Vergata, Rome, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0486
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [21] Optimizing survival outcomes with post-remission therapy in acute myeloid leukemia
    Medeiros, Bruno C.
    Chan, Steven M.
    Daver, Naval G.
    Jonas, Brian A.
    Pollyea, Daniel A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (07) : 803 - 811
  • [22] Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia
    El Kinge, Abdul Rahman
    Hatourn, Hassan A.
    Mahfouz, Rami A.
    Otrock, Zaher K.
    Jabbour, Elias
    Kantarjian, Hagop
    Bazarbachi, Ali
    LEUKEMIA RESEARCH, 2009, 33 (04) : 565 - 566
  • [23] Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Residual Disease as Determined by Flow Cytometry
    Inoue, Daichi
    Maruoka, Hayato
    Takahashi, Takayuki
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2010, 2 (02)
  • [24] Integrating post induction WT1 quantification and flow-cytometry results improves minimal residual disease stratification in acute myeloid leukemia
    Marani, Carlo
    Clavio, Marino
    Grasso, Raffaella
    Colombo, Nicoletta
    Guolo, Fabio
    Kunkl, Annalisa
    Ballerini, Filippo
    Giannoni, Livia
    Ghiggi, Chiara
    Fugazza, Giuseppina
    Ravetti, Jean-Louis
    Gobbi, Marco
    Miglino, Maurizio
    LEUKEMIA RESEARCH, 2013, 37 (12) : 1606 - 1611
  • [25] Impact of pretransplant minimal residual disease detection by flow cytometry in acute myeloid leukemia
    Perez, E.
    Lopez-Godino, O.
    Cabrero, M.
    Labrador, J.
    Alonso, S.
    Perez, J. J.
    Lopez-Corral, L.
    Vazquez, L.
    Gonzalez, M.
    Hernadez, J. M.
    Puig, N.
    Diez-Campelo, M.
    Martin, A.
    Mateos, M. V.
    Paiva, B.
    del Canizo, M. C.
    San Miguel, J.
    Caballero, M. D.
    Vidriales, M. B.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S238 - S239
  • [26] The Role of Multiparameter Flow Cytometry for Detection of Minimal Residual Disease in Acute Myeloid Leukemia
    Al-Mawali, Adhra
    Gillis, David
    Lewis, Ian
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (01) : 16 - 26
  • [27] Defining minimal residual disease by flow cytometry in acute myeloid leukemia: the HARMONIZE initiative
    Buecklein, V. L.
    Krause, S.
    Oelschlaegel, U.
    Koehnke, T.
    Schnorfeil, F.
    Voelkl, S.
    Rieger, M. A.
    Berg, T.
    Hoffmann, J.
    Brendel, C.
    Hiddemann, W.
    Subklewe, M.
    von Bonin, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 43 - 43
  • [28] Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach?
    Derman, Benjamin A.
    Larson, Richard A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
  • [29] A phase II study of post-remission therapy with pembrolizumab in older patients with acute myeloid leukemia
    Quann, Kevin
    Lontos, Konstantinos
    Sehgal, Alison
    Raptis, Anastasios
    Im, Annie
    Redner, Robert L.
    Dorritie, Kathleen A.
    Agha, Mounzer
    Hou, Jing-Zhou
    Farah, Rafic
    Rossetti, James
    Normolle, Daniel P.
    Whiteside, Theresa L.
    Hsu, Yen-Michael Sheng
    Boyiadzis, Michael
    HAEMATOLOGICA, 2024, 109 (12) : 4106 - 4111
  • [30] The Value of Post-Remission Therapy in Older Adults with Acute Myeloid Leukemia (AML).
    Sekeres, Mikkael A.
    Fu, Alex Z.
    Earl, Marc
    Kalaycio, Matt
    Advani, Anjali
    Saunthararajah, Yogen
    Sobecks, Ronald
    Copelan, Edward
    BLOOD, 2009, 114 (22) : 431 - 432
12345